Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT00010322 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped Withdrawn due to change in standard of care - new protocol required

Conditions

Breast Cancer

Interventions

DRUG: atamestane
DRUG: toremifene

Sponsor

Intarcia Therapeutics